AlecBrittMD(He/Him)

Hematology/Oncology

Fellow

Dr. Britt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2021 - 2024
University of Kansas School of MedicineResidency, Internal Medicine, 2018 - 2021
University of Kansas School of MedicineClass of 2018
University of KansasBS, Biology, Cum Laude, 2010 - 2014

PubMed

1 citations
SOHO State of the Art Updates and Next Questions | Early Intervention in Myelofibrosis: Where Are We and Does It Matter?
Abdulraheem Yacoub, Nicole Twardowski, Alec Britt, Nour Shraim
Clinical Lymphoma, Myeloma & Leukemia. 2024-08-01
1 citations
The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma.
Syed Maaz Tariq, Al-Ola Abdallah, Aaron Goodman, Douglas Sborov, Ghulam Rehman Mohyuddin
Clinical Hematology International. 2023-06-01
4 citations
Retrospective Review of Outcomes of Multiple Myeloma (MM) Patients With COVID-19 Infection (Two-Center Study).
Hamid Ehsan, Alec Britt, Peter M Voorhees, Barry Paul, Manisha Bhutani
Clinical Lymphoma, Myeloma & Leukemia. 2023-04-01

Abstracts/Posters

Retrospective review of outcomes of patients with multiple myeloma with COVID-19 infection (two-center study).
Hamid Ehsan, Alec Britt, Peter M. Voorhees, Barry Paul, Manisha Bhutani, Cindy Varga, Zane Chiad, Brittany K. Ragon, Zainab Shahid, Moussa Shahoud, Al-Ola A. Abdallah,..., ASCO 2022 National Meeting, 6/5/2022